Takeover bid for ResApp final says determined Pfizer
MELBOURNE: Pfizer has told ASX-listed ResApp it will not increase its 20.8c per share takeover
MELBOURNE: Pfizer has told ASX-listed ResApp it will not increase its 20.8c per share takeover